Ampio Pharmaceuticals (AMPE)
(Delayed Data from OTC)
$0.21 USD
0.00 (-0.94%)
Updated May 31, 2024 12:37 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
AMPE 0.21 0.00(-0.94%)
Will AMPE be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AMPE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMPE
New Strong Sell Stocks for April 7th
New Strong Sell Stocks for April 1st
AMPE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for AMPE
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation
Biotech Alert: Searches spiking for these stocks today
AMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023
VERI, CHEK and CZOO among mid-day movers
GOEV, NBSE and FLGC among pre-market losers